Code | 7692E | ||||||||||
MA number | 31/0264/24-S | ||||||||||
Product Form: | tbl flm 90x1 (2x45x1)x10 mg/80 mg (blis.OPA/Al/PVC//Al - jednotk.multibal.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister OPA/Al/PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 09.10.2024 |
Validity: | 09.10.2029 |
SPC: | SPC_Ezetimib_Atorvastatín Sandoz_10_2024.pdf |
PIL: | PIL_Ezetimib-Atorvastatín Sandoz_10.2024.pdf |
Safety feature | Yes |
Data update: | 10.10.2024 |